Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer. Ratz L, Brambillasca C, Bartke L, Huetzen MA, et al. Breast Cancer Res 2022;24:41.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ratz L, Brambillasca C, Bartke L, Huetzen MA, et al. Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer. Breast Cancer Res 2022;24:41.
PMID: 35715861